Trent Dixon Davidge

Trent Davidge practices at New Orleans East Hospital in New Orleans, Louisiana, part of LCMC Health.

Trent Davidge's NPI, 1972122711, was assigned on April 12, 2020. Trent Davidge graduated from Louisiana State University School of Medicine in New Orleans in 2020. Trent Davidge holds Louisiana license 335837.

Trent Davidge's primary practice is New Orleans East Hospital, at 5620 Read Blvd, New Orleans, LA 70127 in Orleans Parish. The practice phone is (504) 592-6600.

Trent Davidge's primary practice is New Orleans East Hospital in New Orleans, Louisiana, part of LCMC Health. Trent Davidge is also affiliated with University Medical Center New Orleans. The medical group on file is Crescent City Physicians, Inc. Dmand AI also links Trent Davidge to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Trent Davidge practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Trent Davidge's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Trent Davidge is licensed in Louisiana.

CMS data shows 347 Medicare services from Trent Davidge across 4 procedure codes in 2024, for 113 Medicare patients. Medicare paid $24,668 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Trent Davidge in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Trent Davidge's median patient age at 71, with 43% women.

In 2024, Trent Davidge wrote 476 Medicare Part D claims for 132 patients. 81% of them were for generic drugs. CMS names the drug for 269 of them, across 14 drugs with 11 or more claims each, at $52,086 in total drug cost. In 2023, CMS named 291 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Trent Davidge for performance year 2024, reported as part of a group. Trent Davidge accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 17 general payments to Trent Davidge from 9 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 84% of the total. Abbott Laboratories paid the most, $258.

Trent Davidge graduated from Louisiana State University School of Medicine in New Orleans in 2020.